Trials / Unknown
UnknownNCT02826070
EFFORT Further Extension Study
Efficacy of Long-term Telbivudine Treatment on Histological Improvements in Patients With Chronic Hepatitis B (EFFORT Further Extension Study)
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 130 (actual)
- Sponsor
- Nanfang Hospital, Southern Medical University · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to demonstrate that long-term treatment (up to six years) with telbivudine or telbivudine plus adefovir results in the regression in liver inflammation and fibrosis/cirrhosis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Telbivudine | Telbivudine, 600mg, oral, daily |
| DRUG | Adefovir dipivoxil | Adefovir dipivoxil 10mg, oral, daily |
| OTHER | off-treatment follow-up |
Timeline
- Start date
- 2015-04-01
- Primary completion
- 2016-10-01
- Completion
- 2017-10-01
- First posted
- 2016-07-07
- Last updated
- 2016-07-07
Locations
20 sites across 1 country: China
Source: ClinicalTrials.gov record NCT02826070. Inclusion in this directory is not an endorsement.